The landscape of brain tumor mimics in neuro-oncology practice Lalanthica V. YogendranTuba KaleliogluCamilo E. Fadul Research 20 July 2022 Pages: 499 - 508
Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation Akifumi HagiwaraJacob SchlossmanBenjamin M. Ellingson Research 17 July 2022 Pages: 509 - 518
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression Marguerite MüllerOliver WinzPhilipp Lohmann Research Open access 19 July 2022 Pages: 519 - 529
Characteristics and therapeutic strategies of radiation-induced glioma: case series and comprehensive literature review Shumpei OnishiFumiyuki YamasakiKazuhiko Sugiyama Research 03 August 2022 Pages: 531 - 538
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review Ashray GunjurAdithya BalasubramanianHui Kong Gan Review 06 August 2022 Pages: 539 - 549
Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review Ashray GunjurAdithya BalasubramanianHui Kong Gan Correction 22 August 2022 Pages: 551 - 551
Readmission risk of malignant brain tumor patients undergoing laser interstitial thermal therapy (LITT) and stereotactic needle biopsy (SNB): a covariate balancing weights analysis of the National Readmissions Database (NRD) Truong H. DoMadeleine A. HowardClark C. Chen Research 23 July 2022 Pages: 553 - 561
An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registry Ashley S. Plant-FoxTomonari SuzukiMark W. Kieran Research 02 August 2022 Pages: 563 - 570
Glioblastoma multiforme in patients with human immunodeficiency virus: an integrated review and analysis Mynor J. Mendez ValdezVictor M. LuAshish H. Shah Review 20 July 2022 Pages: 571 - 579
Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma Hirotaka HasegawaMasahiro ShinNobuhito Saito Research 26 July 2022 Pages: 581 - 590
Safety of temozolomide use in adult patients with renal dysfunction Kayla GarzioKelly McElroyOlga Yankulina Research 24 August 2022 Pages: 591 - 596
Preservation of endocrine function after Ommaya reservoir insertion in children with cystic craniopharyngioma Laura-Nanna LohkampAbhaya V. KulkarniUte K. Bartels Research 04 August 2022 Pages: 597 - 607
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases Brandon S. ImberRobert J. YoungNelson S. Moss Research 27 July 2022 Pages: 609 - 618
Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases Brandon S. ImberRobert J. YoungNelson S. Moss Correction 23 August 2022 Pages: 619 - 619
The use of telemedicine in pre-surgical evaluation: a retrospective cohort study of a neurosurgical oncology practice Rupert D. SmitNikolaos MouchtourisJames J. Evans Research 28 July 2022 Pages: 621 - 626
The impact of expanded endoscopic approaches on oncologic and functional outcomes for clival malignancies:a case series Solon SchurJoel Z. PasserShaan M. Raza Research 16 August 2022 Pages: 627 - 635
Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial Nathan S. FishbeinAna-Maria VranceanuRyan A. Mace Research 04 August 2022 Pages: 637 - 646
Prognostic factors among patients with brain metastases from cancer of unknown primary site C. Simões PadillaV. K. Y. HoC. Loef Research 17 August 2022 Pages: 647 - 655
Impact of seizures and antiseizure medication on survival in patients with glioma Thinisha Sathis KumarWan Muhammad AfnanVairavan Narayanan Case Study 29 August 2022 Pages: 657 - 664
Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy Seth A. ClimansWarren P. MasonKelvin Chan Research 06 August 2022 Pages: 665 - 674
EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases Hung-Ruei LiaoChi-Lu ChiangCheng-Chia Lee Research 17 August 2022 Pages: 675 - 684
Outcomes of first-line anti-PD-L1 blockades combined with brain radiotherapy for extensive-stage small-cell lung cancer with brain metastasis Ji MaYaru TianHui Zhu Research 17 August 2022 Pages: 685 - 693
Sex as a prognostic factor in adult-type diffuse gliomas: an integrated clinical and molecular analysis according to the 2021 WHO classification Minjae KimSooyon KimSeung-Koo Lee Research 21 August 2022 Pages: 695 - 703
Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volume Michael YanLori HoldenZain Husain Research 24 August 2022 Pages: 705 - 712
Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up Robyn E. PartinMatthew D. WogkschKirsten K. Ness Research 20 August 2022 Pages: 713 - 723
The role of methylation profiling in histologically diagnosed neurocytoma: a case series Adam Z. KalawiDenise M. MalickiJohn R. Crawford Research Open access 22 August 2022 Pages: 725 - 733
